Cargando…

Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso

BACKGROUND: Seasonal malaria chemoprevention (SMC) involves administering antimalarial drugs at monthly intervals during the high malaria transmission period to children aged 3 to 59 months as recommended by the World Health Organization. Typically, a full SMC course is administered over four monthl...

Descripción completa

Detalles Bibliográficos
Autores principales: Traore, Adama, Donovan, Laura, Sawadogo, Benoit, Ward, Charlotte, Smith, Helen, Rassi, Christian, Counihan, Helen, Johansson, Johanna, Richardson, Sol, Savadogo, Justin Ragnessi, Baker, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897918/
https://www.ncbi.nlm.nih.gov/pubmed/35247990
http://dx.doi.org/10.1186/s12889-022-12741-9
_version_ 1784663532600557568
author Traore, Adama
Donovan, Laura
Sawadogo, Benoit
Ward, Charlotte
Smith, Helen
Rassi, Christian
Counihan, Helen
Johansson, Johanna
Richardson, Sol
Savadogo, Justin Ragnessi
Baker, Kevin
author_facet Traore, Adama
Donovan, Laura
Sawadogo, Benoit
Ward, Charlotte
Smith, Helen
Rassi, Christian
Counihan, Helen
Johansson, Johanna
Richardson, Sol
Savadogo, Justin Ragnessi
Baker, Kevin
author_sort Traore, Adama
collection PubMed
description BACKGROUND: Seasonal malaria chemoprevention (SMC) involves administering antimalarial drugs at monthly intervals during the high malaria transmission period to children aged 3 to 59 months as recommended by the World Health Organization. Typically, a full SMC course is administered over four monthly cycles from July to October, coinciding with the rainy season. However, an analysis of rainfall patterns suggest that the malaria transmission season is longer and starting as early as June in the south of Burkina Faso, leading to a rise in cases prior to the first cycle. This study assessed the acceptability and feasibility of extending SMC from four to five cycles to coincide with the earlier rainy season in Mangodara health district. METHODS: The mixed-methods study was conducted between July and November 2019. Quantitative data were collected through end-of-cycle and end-of-round household surveys to determine the effect of the additional cycle on the coverage of SMC in Mangodara. The data were then compared with 22 other districts where SMC was implemented by Malaria Consortium. Eight focus group discussions were conducted with caregivers and community distributors and 11 key informant interviews with community, programme and national-level stakeholders. These aimed to determine perceptions of the acceptability and feasibility of extending SMC to five cycles. RESULTS: The extension was perceived as acceptable by caregivers, community distributors and stakeholders due to the positive impact on the health of children under five. However, many community distributors expressed concern over the feasibility, mainly due to the clash with farming activities in June. Stakeholders highlighted the need for more evidence on the impact of the additional cycle on parasite resistance prior to scale-up. End-of-cycle survey data showed no difference in coverage between five SMC cycles in Mangodara and four cycles in the 22 comparison districts. CONCLUSIONS: The additional cycle should begin early in the day in order to not coincide with the agricultural activities of community distributors. Continuous sensitisation at community level is critical for the sustainability of SMC and acceptance of an additional cycle, which should actively engage male caregivers. Providing additional support in proportion to the increased workload from a fifth cycle, including timely remuneration, is critical to avoid the demotivation of community distributors. Further studies are required to understand the effectiveness, including cost-effectiveness, of tailoring SMC according to the rainy season. Understanding the impact of an additional cycle on parasite resistance to SPAQ is critical to address key informants’ concerns around the deviation from the current four-cycle policy recommendation.
format Online
Article
Text
id pubmed-8897918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88979182022-03-16 Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso Traore, Adama Donovan, Laura Sawadogo, Benoit Ward, Charlotte Smith, Helen Rassi, Christian Counihan, Helen Johansson, Johanna Richardson, Sol Savadogo, Justin Ragnessi Baker, Kevin BMC Public Health Research BACKGROUND: Seasonal malaria chemoprevention (SMC) involves administering antimalarial drugs at monthly intervals during the high malaria transmission period to children aged 3 to 59 months as recommended by the World Health Organization. Typically, a full SMC course is administered over four monthly cycles from July to October, coinciding with the rainy season. However, an analysis of rainfall patterns suggest that the malaria transmission season is longer and starting as early as June in the south of Burkina Faso, leading to a rise in cases prior to the first cycle. This study assessed the acceptability and feasibility of extending SMC from four to five cycles to coincide with the earlier rainy season in Mangodara health district. METHODS: The mixed-methods study was conducted between July and November 2019. Quantitative data were collected through end-of-cycle and end-of-round household surveys to determine the effect of the additional cycle on the coverage of SMC in Mangodara. The data were then compared with 22 other districts where SMC was implemented by Malaria Consortium. Eight focus group discussions were conducted with caregivers and community distributors and 11 key informant interviews with community, programme and national-level stakeholders. These aimed to determine perceptions of the acceptability and feasibility of extending SMC to five cycles. RESULTS: The extension was perceived as acceptable by caregivers, community distributors and stakeholders due to the positive impact on the health of children under five. However, many community distributors expressed concern over the feasibility, mainly due to the clash with farming activities in June. Stakeholders highlighted the need for more evidence on the impact of the additional cycle on parasite resistance prior to scale-up. End-of-cycle survey data showed no difference in coverage between five SMC cycles in Mangodara and four cycles in the 22 comparison districts. CONCLUSIONS: The additional cycle should begin early in the day in order to not coincide with the agricultural activities of community distributors. Continuous sensitisation at community level is critical for the sustainability of SMC and acceptance of an additional cycle, which should actively engage male caregivers. Providing additional support in proportion to the increased workload from a fifth cycle, including timely remuneration, is critical to avoid the demotivation of community distributors. Further studies are required to understand the effectiveness, including cost-effectiveness, of tailoring SMC according to the rainy season. Understanding the impact of an additional cycle on parasite resistance to SPAQ is critical to address key informants’ concerns around the deviation from the current four-cycle policy recommendation. BioMed Central 2022-03-05 /pmc/articles/PMC8897918/ /pubmed/35247990 http://dx.doi.org/10.1186/s12889-022-12741-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Traore, Adama
Donovan, Laura
Sawadogo, Benoit
Ward, Charlotte
Smith, Helen
Rassi, Christian
Counihan, Helen
Johansson, Johanna
Richardson, Sol
Savadogo, Justin Ragnessi
Baker, Kevin
Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title_full Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title_fullStr Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title_full_unstemmed Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title_short Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso
title_sort extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in mangodara district, burkina faso
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897918/
https://www.ncbi.nlm.nih.gov/pubmed/35247990
http://dx.doi.org/10.1186/s12889-022-12741-9
work_keys_str_mv AT traoreadama extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT donovanlaura extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT sawadogobenoit extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT wardcharlotte extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT smithhelen extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT rassichristian extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT counihanhelen extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT johanssonjohanna extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT richardsonsol extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT savadogojustinragnessi extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso
AT bakerkevin extendingseasonalmalariachemopreventiontofivecyclesapilotstudyoffeasibilityandacceptabilityinmangodaradistrictburkinafaso